Anatol Kreitzer

Chief Discovery Officer, MapLight Therapeutics, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Aug 17, 2026Granted 6,020 shares of MapLight Therapeutics, Inc.²
Jul 17, 2026Sold 200 shares at $38.39 of MapLight Therapeutics, Inc.³
Jul 17, 2026Sold 14,140 shares at $37.70 of MapLight Therapeutics, Inc.³
Jul 17, 2026Sold 2,833 shares at $37.05 of MapLight Therapeutics, Inc.³
Jul 16, 2026Sold 1,592 shares at $37.44 of MapLight Therapeutics, Inc.³
Jul 16, 2026Sold 7,464 shares at $36.66 of MapLight Therapeutics, Inc.³
Jul 15, 2026Sold 4,510 shares at $36.94 of MapLight Therapeutics, Inc.³
Jul 15, 2026Sold 5,545 shares at $36.13 of MapLight Therapeutics, Inc.³
Apr 27, 2026Sold 7,821 shares at $30.50 of MapLight Therapeutics, Inc.⁴
Apr 27, 2026Sold 29,255 shares at $29.63 of MapLight Therapeutics, Inc.⁴
Apr 27, 2026Sold 8,346 shares at $28.96 of MapLight Therapeutics, Inc.⁴
Apr 15, 2026Sold 3,316 shares at $26.61 of MapLight Therapeutics, Inc.⁵
Feb 5, 2026Granted 6,020 shares of MapLight Therapeutics, Inc.⁶
Jan 27, 2026Shares withheld for tax 42,099 shares at $17.98 of MapLight Therapeutics, Inc.⁷
Oct 27, 2025Granted 35,953 shares of MapLight Therapeutics, Inc.⁸

The numbers on this page point here. Each one links to the record it came from.